APO RESEARCH · REPORT
Immune Health Product
Immune health products are health products that can improve immunity and promote metabolism.
Product & engineering
Understand the product.
Immune health products are health products that can improve immunity and promote metabolism.
Selected research
Market Structure
Global Immune Health Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Immune health products are health products that can improve immunity and promote metabolism.
Global Immune Health Product key players include Amway, Suntory, GNC, INFINITUS, Herbalife Nutrition, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe and China, both have a share over 37 percent. In terms of product, Capsule/Pills is the largest segment, with a share over 81%. And in terms of End User, the largest End User is Adults, followed by Men, etc.
Report Includes
Read the full market overview
This report provides an overview of the global Immune Health Product market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Immune Health Product and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Immune Health Product revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Immune Health Product market size, projected growth trends, production technologies, key applications, and end-use industries.
Immune Health Product Segment by Company
Amway
Suntory
GNC
INFINITUS
Herbalife Nutrition
USANA Health Sciences, Inc.
PERFECT
Nestlé SA
H&H Group
China New Era Group
By-health
Black Mores
Glanbia Plc
Nature’s
Real Nutriceutical
Immune Health Product Segment by Form
Capsule/Pills
Powder
Liquid
Immune Health Product Segment by End Users
Children/Teenagers
Men
Adults
The Elderly
Immune Health Product Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Health Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Immune Health Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune Health Product industry.
Chapter 3: Detailed analysis of Immune Health Product companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Health Productrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule/Pills
- Powder
- Liquid
Applications
- Children/Teenagers
- Men
- Adults
- The Elderly
Companies covered
- Amway
- Suntory
- GNC
- INFINITUS
- Herbalife Nutrition
- USANA Health Sciences, Inc.
- PERFECT
- Nestlé SA
- H&H Group
- China New Era Group
- By-health
- Black Mores
- Glanbia Plc
- Nature’s
- Real Nutriceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Immune Health Product Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Capsule/Pills
- 1.2.3 Powder
- 1.2.4 Liquid
- 1.3 Market Analysis by Application
- 1.3.1 Global Immune Health Product Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Children/Teenagers
- 1.3.3 Men
- 1.3.4 Adults
- 1.3.5 The Elderly
- 1.4 Global Market Growth Prospects
- 1.5 Global Immune Health Product Growth Trends by Region
- 1.5.1 Global Immune Health Product Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Immune Health Product Market Size by Region (2021-2026)
- 1.5.3 Immune Health Product Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Immune Health Product Market Dynamics
- 2.1 Immune Health Product Industry Trends
- 2.2 Immune Health Product Industry Drivers
- 2.3 Immune Health Product Industry Opportunities and Challenges
- 2.4 Immune Health Product Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Immune Health Product Revenue by Company (2021-2026)
- 3.2 Global Immune Health Product Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Immune Health Product Key Company Head office and Area Served
- 3.4 Global Immune Health Product Company, Product Type & Application
- 3.5 Global Immune Health Product Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Immune Health Product Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Immune Health Product Players Market Share by Revenue in 2025
- 3.6.3 2025 Immune Health Product Tier 1, Tier 2, and Tier 3
4 Immune Health Product Market by Type
- 4.1 Global Immune Health Product Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Immune Health Product Market Size by Type (2021-2032)
- 4.3 Global Immune Health Product Market Size Share by Type (2021-2032)
5 Immune Health Product Market by Application
- 5.1 Global Immune Health Product Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Immune Health Product Market Size by Application (2021-2032)
- 5.3 Global Immune Health Product Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Amway
- 6.1.1 Amway Company Information
- 6.1.2 Amway Business Overview
- 6.1.3 Amway Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Amway Immune Health Product Product Portfolio
- 6.1.5 Amway Recent Developments
- 6.2 Suntory
- 6.2.1 Suntory Company Information
- 6.2.2 Suntory Business Overview
- 6.2.3 Suntory Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Suntory Immune Health Product Product Portfolio
- 6.2.5 Suntory Recent Developments
- 6.3 GNC
- 6.3.1 GNC Company Information
- 6.3.2 GNC Business Overview
- 6.3.3 GNC Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GNC Immune Health Product Product Portfolio
- 6.3.5 GNC Recent Developments
- 6.4 INFINITUS
- 6.4.1 INFINITUS Company Information
- 6.4.2 INFINITUS Business Overview
- 6.4.3 INFINITUS Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 INFINITUS Immune Health Product Product Portfolio
- 6.4.5 INFINITUS Recent Developments
- 6.5 Herbalife Nutrition
- 6.5.1 Herbalife Nutrition Company Information
- 6.5.2 Herbalife Nutrition Business Overview
- 6.5.3 Herbalife Nutrition Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Herbalife Nutrition Immune Health Product Product Portfolio
- 6.5.5 Herbalife Nutrition Recent Developments
- 6.6 USANA Health Sciences, Inc.
- 6.6.1 USANA Health Sciences, Inc. Company Information
- 6.6.2 USANA Health Sciences, Inc. Business Overview
- 6.6.3 USANA Health Sciences, Inc. Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 USANA Health Sciences, Inc. Immune Health Product Product Portfolio
- 6.6.5 USANA Health Sciences, Inc. Recent Developments
- 6.7 PERFECT
- 6.7.1 PERFECT Company Information
- 6.7.2 PERFECT Business Overview
- 6.7.3 PERFECT Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 PERFECT Immune Health Product Product Portfolio
- 6.7.5 PERFECT Recent Developments
- 6.8 Nestlé SA
- 6.8.1 Nestlé SA Company Information
- 6.8.2 Nestlé SA Business Overview
- 6.8.3 Nestlé SA Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Nestlé SA Immune Health Product Product Portfolio
- 6.8.5 Nestlé SA Recent Developments
- 6.9 H&H Group
- 6.9.1 H&H Group Company Information
- 6.9.2 H&H Group Business Overview
- 6.9.3 H&H Group Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 H&H Group Immune Health Product Product Portfolio
- 6.9.5 H&H Group Recent Developments
- 6.10 China New Era Group
- 6.10.1 China New Era Group Company Information
- 6.10.2 China New Era Group Business Overview
- 6.10.3 China New Era Group Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 China New Era Group Immune Health Product Product Portfolio
- 6.10.5 China New Era Group Recent Developments
- 6.11 By-health
- 6.11.1 By-health Company Information
- 6.11.2 By-health Business Overview
- 6.11.3 By-health Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 By-health Immune Health Product Product Portfolio
- 6.11.5 By-health Recent Developments
- 6.12 Black Mores
- 6.12.1 Black Mores Company Information
- 6.12.2 Black Mores Business Overview
- 6.12.3 Black Mores Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Black Mores Immune Health Product Product Portfolio
- 6.12.5 Black Mores Recent Developments
- 6.13 Glanbia Plc
- 6.13.1 Glanbia Plc Company Information
- 6.13.2 Glanbia Plc Business Overview
- 6.13.3 Glanbia Plc Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Glanbia Plc Immune Health Product Product Portfolio
- 6.13.5 Glanbia Plc Recent Developments
- 6.14 Nature’s
- 6.14.1 Nature’s Company Information
- 6.14.2 Nature’s Business Overview
- 6.14.3 Nature’s Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Nature’s Immune Health Product Product Portfolio
- 6.14.5 Nature’s Recent Developments
- 6.15 Real Nutriceutical
- 6.15.1 Real Nutriceutical Company Information
- 6.15.2 Real Nutriceutical Business Overview
- 6.15.3 Real Nutriceutical Immune Health Product Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Real Nutriceutical Immune Health Product Product Portfolio
- 6.15.5 Real Nutriceutical Recent Developments
7 North America
- 7.1 North America Immune Health Product Market Size (2021-2032)
- 7.2 North America Immune Health Product Market Size by Type
- 7.2.1 North America Immune Health Product Market Size by Type (2021-2026)
- 7.2.2 North America Immune Health Product Market Size by Type (2027-2032)
- 7.2.3 North America Immune Health Product Market Share by Type (2021-2032)
- 7.3 North America Immune Health Product Market Size by Application
- 7.3.1 North America Immune Health Product Market Size by Application (2021-2026)
- 7.3.2 North America Immune Health Product Market Size by Application (2027-2032)
- 7.3.3 North America Immune Health Product Market Share by Application (2021-2032)
- 7.4 North America Immune Health Product Market Size by Country
- 7.4.1 North America Immune Health Product Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Immune Health Product Market Size by Country (2021-2026)
- 7.4.3 North America Immune Health Product Market Size by Country (2027-2032)
- 7.4.4 North America Immune Health Product Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Immune Health Product Market Size (2021-2032)
- 8.2 Europe Immune Health Product Market Size by Type
- 8.2.1 Europe Immune Health Product Market Size by Type (2021-2026)
- 8.2.2 Europe Immune Health Product Market Size by Type (2027-2032)
- 8.2.3 Europe Immune Health Product Market Share by Type (2021-2032)
- 8.3 Europe Immune Health Product Market Size by Application
- 8.3.1 Europe Immune Health Product Market Size by Application (2021-2026)
- 8.3.2 Europe Immune Health Product Market Size by Application (2027-2032)
- 8.3.3 Europe Immune Health Product Market Share by Application (2021-2032)
- 8.4 Europe Immune Health Product Market Size by Country
- 8.4.1 Europe Immune Health Product Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Immune Health Product Market Size by Country (2021-2026)
- 8.4.3 Europe Immune Health Product Market Size by Country (2027-2032)
- 8.4.4 Europe Immune Health Product Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Immune Health Product Market Size (2021-2032)
- 9.2 China Immune Health Product Market Size by Type
- 9.2.1 China Immune Health Product Market Size by Type (2021-2026)
- 9.2.2 China Immune Health Product Market Size by Type (2027-2032)
- 9.2.3 China Immune Health Product Market Share by Type (2021-2032)
- 9.3 China Immune Health Product Market Size by Application
- 9.3.1 China Immune Health Product Market Size by Application (2021-2026)
- 9.3.2 China Immune Health Product Market Size by Application (2027-2032)
- 9.3.3 China Immune Health Product Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Immune Health Product Market Size (2021-2032)
- 10.2 Asia Immune Health Product Market Size by Type
- 10.2.1 Asia Immune Health Product Market Size by Type (2021-2026)
- 10.2.2 Asia Immune Health Product Market Size by Type (2027-2032)
- 10.2.3 Asia Immune Health Product Market Share by Type (2021-2032)
- 10.3 Asia Immune Health Product Market Size by Application
- 10.3.1 Asia Immune Health Product Market Size by Application (2021-2026)
- 10.3.2 Asia Immune Health Product Market Size by Application (2027-2032)
- 10.3.3 Asia Immune Health Product Market Share by Application (2021-2032)
- 10.4 Asia Immune Health Product Market Size by Country
- 10.4.1 Asia Immune Health Product Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Immune Health Product Market Size by Country (2021-2026)
- 10.4.3 Asia Immune Health Product Market Size by Country (2027-2032)
- 10.4.4 Asia Immune Health Product Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Immune Health Product Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Immune Health Product Market Size by Type
- 11.2.1 South America, Middle East & Africa Immune Health Product Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Immune Health Product Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Immune Health Product Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Immune Health Product Market Size by Application
- 11.3.1 South America, Middle East & Africa Immune Health Product Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Immune Health Product Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Immune Health Product Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Immune Health Product Market Size by Country
- 11.4.1 South America, Middle East & Africa Immune Health Product Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Immune Health Product Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Immune Health Product Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Immune Health Product Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst